TGFB1 and pulmonary fibrosis: More recently, dopamine receptor agonists, including fenoldopam (D1R-selective), have been found to mitigate myofibroblast differentiation and TGF-β/Smad2 signaling in bleomycin-induced pulmonary fibrosis models, supporting a novel neuromodulatory mechanism of fibrosis control [44].